Sitagliptin, a dipeptidyl peptidase-4 inhibitor, was selected as an active-comparator placebo proxy because it was recommended in clinical guidelines as a second-line glucose-lowering therapy, had a similar high cost to the study drugs, showed no effect on cardiovascular outcomes in a large randomized controlled trial and has been validated as a placebo proxy in prior claims-based research 20,41
This is typically mild and improves as your body adapts
It has shown particular promise in managing disorders such as vitiligo and erythropoietic protoporphyria, where pigmentation enhancement can improve quality of life
acnes immunostimulation in horses and show that antimicrobial peptides are not only interesting as drugs, but also as endogenous agents that can be stimulated by immunomodulatory substances to promote the immune system
Exenatide, a first-generation GLP-1 agonist, mitigated vascular aging induced by a high-fat diet in ApoE-/- mice by regulating inflammation and oxidative stress responses [55]
PMID 12163482